Mylan Pharmaceuticals Inc. recalls Amlodipine and Benazapril HCL Capsules, USP, 5 mg/40 mg, 100 count bottles, Mylan Pharmaceuticals, Inc., Morgantown, WV
Recalled May 23, 2018 · FDA recall D-0820-2018 · Mylan Pharmaceuticals
Hazard
cGMP Deviations; cleaning processes for equipment used to manufacture the specified batches was not followed according to procedure · FDA Class II
Units
12,924 bottles
Sold at
Product was distributed throughout United States
Description
cGMP Deviations; cleaning processes for equipment used to manufacture the specified batches was not followed according to procedure
Product
Amlodipine and Benazapril HCL Capsules, USP, 5 mg/40 mg, 100 count bottles, Mylan Pharmaceuticals, Inc., Morgantown, WV --- NDC 0378-6899-01
Manufacturer(s)
Mylan Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →